Pharmaceutics

Pharmaceutics · ISSN (print) 1999-4923 · 4 papers in corpus
review 2024
doi:10.3390/pharmaceutics16111475 ·PMID:39598598

The prevalence of female reproductive system disorders is increasing, especially among women of reproductive age, significantly impacting their quality of life and overall health. Managing these diseases effectively is challenging due to th…

article 2023
doi:10.3390/pharmaceutics15082108 ·PMID:37631322

Anti-angiogenic RNAi-based therapy can be considered as a possible strategy for the treatment of endometriosis (EM), which is the most common gynecological disease. Targeted delivery of siRNA therapeutics is a prerequisite for successful tr…

other 2021
doi:10.3390/pharmaceutics13101618 ·PMID:34683911

Gene therapy is a powerful tool for the development of new treatment strategies for various conditions, by aiming to transport biologically active nucleic acids into diseased cells. To achieve that goal, we used highly potential delivery ve…

article 2021
doi:10.3390/pharmaceutics13070931 ·PMID:34201532

Endometriosis is a gynecological disease defined by the presence of endometrial tissue outside the uterus. To date, the effective treatment of this disease is still based on invasive surgery or laparoscopy. Chelidonium majus L. (Papaveracea…